@see2sea Where did you get the info that next month only start operation in China. Can share the info? Thanks

Well explained article regarding the budget vote yesterday. The debate regarding each ministry's allocation will continue next week and there will certainly be further amendments to budget 2021

https://www.malaysiakini.com/news/552713

lol this oskchoon again....hahahaha.. funny fella

Time to look to Asia for Covid-19 vaccines, says expert

A virologist believes Malaysia should look to Asia for Covid-19 vaccines as those developed in the west have been snapped up by richer countries.

Dr Lam Sai Kit said while it was admirable that Pfizer and BioNTech had produced a vaccine with high efficacy in record time, it would be difficult for Malaysia to access them due to strong competition.

Speaking to FMT, he said with the Covid-19 cases surging in the US and Europe as winter approaches, 80% of Pfizer’s vaccines have been sold to the richest governments around the world.

“China, which has several candidate vaccines in Phase Three clinical trials, and has been tested extensively in and outside of China, including Brazil, had promised to make their vaccine available globally when it is ready for application after the successful completion of the clinical trials,” he said.

https://www.freemalaysiatoday.com/category/nation/2020/11/24/time-to-look-to-asia-for-covid-19-vaccines-says-expert/

Innovative materials from bamboo are helping a new industry to sprout

https://www.economist.com/business/2018/01/20/innovative-materials-from-bamboo-are-helping-a-new-industry-to-sprout

https://www.theborneopost.com/2017/05/20/bamboo-a-green-gold-mine-of-vast-opportunities/

https://news.cgtn.com/news/7a416a4d33454464776c6d636a4e6e62684a4856/share_p.html

Automatic approval for extended moratorium on loan repayment for B40 and micro enterprises

https://www.theedgemarkets.com/article/automatic-approval-extended-moratorium-loan-repayment-b40-and-micro-enterprises

Yang di-Pertuan Agong Sultan Abdullah Sultan Ahmad Shah has thanked MPs for passing the federal budget in the Dewan Rakyat.

A statement from Istana Negara said the King welcomed the support from MPs in ensuring the well-being of the people and the country’s economic recovery.

“He also expresses his appreciation for MPs who heeded his advice to support the budget for the well-being of the people,” said Comptroller of the Royal Household Ahmad Fadil Shamsuddin.

https://www.freemalaysiatoday.com/category/nation/2020/11/26/king-thanks-mps-for-passing-federal-budget/

“The King also welcomes the commitment given by the Chinese government to list Malaysia as the main recipient country of the Covid-19 vaccine they are developing, ” he added.


His Majesty said he hoped that the supply of Covid-19 vaccine to Malaysia could be accelerated and also be a catalyst for the expansion of scientific cooperation and collaboration between the two countries.

https://www.thestar.com.my/news/nation/2020/11/26/king-bids-goodbye-expresses-thanks-to-chinese-ambassador-bai-tian

Malaysia Among First To Receive Chinese-Made Vaccine Against COVID-19 - Reports

Malaysia is expected to be one of the first countries to receive a Chinese-made vaccine against the coronavirus disease, Prime Minister Muhyiddin Yassin said on Thursday, as cited by the state-run Bernama agency

https://www.urdupoint.com/en/world/malaysia-among-first-to-receive-chinese-made-1097071.html

Malaysia has been listed as one of the countries to be given priority to receive the COVID-19 vaccine from China, which will be distributed soon, according to Prime Minister Muhyiddin Yassin.

In a Facebook post on Thursday (Nov 26), the prime minister said the assurance was conveyed to him by China’s outgoing ambassador to Malaysia, Bai Tian, during a farewell visit at the parliament building on Wednesday.

https://www.channelnewsasia.com/news/asia/malaysia-china-covid-19-vaccine-priority-recipient-list-13643988

AstraZeneca Plc and the University of Oxford face mounting questions about their Covid-19 vaccine trial results after acknowledging a manufacturing error.

While an announcement earlier this week by Astra and Oxford showed their shot was 70% effective on average in a late-stage study, the scant details released by the U.K. partners have sparked worries, with some expressing doubts about whether U.S. regulators would clear it.

Astra and Oxford had said their vaccine was 90% effective when a half-dose was given before a full-dose booster. Two full doses showed an efficacy of 62%. But the head of the U.S. vaccine program known as Operation Warp Speed said the next day that the dose showing the higher level of effectiveness was tested in a younger population.

“The most likely explanation for the divergent efficacy in its interim analysis is either chance or patient demographics,” Sam Fazeli, a Bloomberg Intelligence analyst, wrote in a note. “Either way, approval based on current data means people will e inoculated with a vaccine the true efficacy of which is unknown.”

https://www.theedgemarkets.com/article/astrazeneca-faces-more-vaccine-questions-after-manufacturing-error

@oskchoon Lol look whos talking.. hahah weirdo...No need to keep parroting whatever i say to you LOLOL.

If you cannot take my criticism then move on to another forum lol

@oskchoon Me acting emotionally lol joker . You are the one come here and display your frustrations for all to read. Don’t be so childish LOL

Yes bamboo is considered green gold now...the future is bright for bamboo industry. Demand for bamboo is increasing worldwide..

@oskchoon Freedom of speech goes both ways. You can criticize all you want and i also have a right to criticize you and ask you to move on to other counters. If you dont like my criticism, then just leave. No need to be such a snowflake here LOL !

Good don’t want it to be goreng stock

Anyone can verify the status of completion of the private placement ? How many more tranches/ shares ?

Whoever unable to wait until first quarter next year, better move on to other counters...

Okay to each his own.....

This counter is only suitable for patient people willing to hold medium to long term. If unable to hold or wait patiently, better move to other counters.

lol @okschoon if you are unable to tahan the manipulation in this counter, then just move on to other counters lah no need to stress yourself up here

@SleepingForest @1212trade You guys also can move on to other countes. This counter rnot suitable for you.

@oskchoon This counter is not for you then since you are too impatient. Go to other counters like AT then.

Anyone understand the budget vote system ? From article below, sounds like its not over yet

--------------------

Malaysia Leader Wins Budget Vote, Passing Key Leadership Test

The results will ensure Muhyiddin, who took power in March, remains in office for now as the budget enters a second round of debates next week.

https://klse.i3investor.com/servlets/stk/0170.jsp

Malaysia's parliament approves 2021 budget in win for PM Muhyiddin

https://nationalpost.com/pmn/news-pmn/crime-pmn/malaysias-parliament-approves-2021-budget-in-win-for-pm-muhyiddin

Lol you guys very funny down one or two cents already panic. Tired of posting here. As for me, i will be keeping long term. If you guys unable to wait, go ahead to other counters.

70% target for Covid-19 vaccination in Malaysia will focus on adult group — Khairy

https://www.theedgemarkets.com/article/70-target-covid19-vaccination-malaysia-will-focus-adult-group-—-khairy

https://www.globaltimes.cn/content/1208076.shtml

https://www.business-standard.com/article/international/china-vaccine-maker-applies-for-public-use-of-covid-19-shot-report-120112600080_1.html

China’s Sinopharm Seeking Approval for COVID-19 Vaccine

In July, China’s National Medical Products Administration announced a new set of guidelines, aiming to fast-track drug review and approval processes. The regulation specifically said “breakthrough pharmaceuticals” and products that “prevent and treat major infectious diseases” would qualify for an EXPEDITED approval process, even if they had not completed late-stage human trials.

K-Star sees opportunity in distributing Covid-19 vaccines to private clinics

"For a start, we will be establishing a mobile sales and marketing team to approach the private clinics throughout Malaysia," KSS executive chairman Ding Jianpinghe said in a statement today.

KSS is an appointed sale agent to distribute Covid-19 vaccines by Kanger International Bhd (KIB) which has signed a collaboration agreement with China-based Sinopharm Group Hunan Changde Medical Co Ltd to distribute Covid-19 vaccines developed by China National Pharmaceutical Group Corporation (CNPG).

The key person who will be spearheading this initiative is KSS executive director Koo Kien Yoon, who had been the executive director of Biosis Group Bhd (BGB) from 2013 to 2016 where he spearheaded the sales, marketing and distribution of healthcare and pharmaceutical products for the company.

With his established business network as well as personal experience in the industry, KSS would be able to leverage on Koo's prior experience and knowledge to establish a leading market position in this business of distributing Covid-19 vaccines to private clinics in Malaysia.

As a sale agent, KSS would be handling the sales and marketing of the vaccines while KIB would be responsible for the purchasing and inventory holding of the vaccines.

"We are pleased to be working together with KIB on the distribution of Covid-19 vaccines by CNPG, one of China's leading vaccine producers.


https://www.nst.com.my/business/2020/11/644297/k-star-sees-opportunity-distributing-covid-19-vaccines-private-clinics

K-Star sees opportunity in distributing Covid-19 vaccines to private clinics

"For a start, we will be establishing a mobile sales and marketing team to approach the private clinics throughout Malaysia," KSS executive chairman Ding Jianpinghe said in a statement today.

KSS is an appointed sale agent to distribute Covid-19 vaccines by Kanger International Bhd (KIB) which has signed a collaboration agreement with China-based Sinopharm Group Hunan Changde Medical Co Ltd to distribute Covid-19 vaccines developed by China National Pharmaceutical Group Corporation (CNPG).

The key person who will be spearheading this initiative is KSS executive director Koo Kien Yoon, who had been the executive director of Biosis Group Bhd (BGB) from 2013 to 2016 where he spearheaded the sales, marketing and distribution of healthcare and pharmaceutical products for the company.

With his established business network as well as personal experience in the industry, KSS would be able to leverage on Koo's prior experience and knowledge to establish a leading market position in this business of distributing Covid-19 vaccines to private clinics in Malaysia.

As a sale agent, KSS would be handling the sales and marketing of the vaccines while KIB would be responsible for the purchasing and inventory holding of the vaccines.

"We are pleased to be working together with KIB on the distribution of Covid-19 vaccines by CNPG, one of China's leading vaccine producers.


https://www.nst.com.my/business/2020/11/644297/k-star-sees-opportunity-distributing-covid-19-vaccines-private-clinics

https://www.scmp.com/news/china/society/article/3111347/coronavirus-sinopharm-applies-regulatory-approval-china-launch

Dr M open to cooperate with Muhyiddin despite objecting Budget 2021

https://www.malaysiakini.com/news/552546

Ahead of Budget 2021 vote, Perikatan backbenchers vow support for Muhyiddin

MPs in the Perikatan Nasional (PN) Backbenchers Club (PNBBC) have unanimously expressed support to approve Budget 2021 tomorrow.

PNBBC comprises MPs from Barisan Nasional (BN), Bersatu, PAS, Parti Solidariti Tanah Airku (STAR), Gabungan Parti Sarawak (GPS) as well as independents.

The Supply Bill 2021 is expected to be voted on tomorrow after the remaining nine ministers have wound up the debates for their respective ministries.

https://www.malaymail.com/news/malaysia/2020/11/25/ahead-of-budget-2021-vote-perikatan-backbenchers-vow-support-for-muhyiddin/1926116

Lets wait and see...

UAE: Buying more vaccine-related stocks can help ride the next big investment boom

Looking to invest your hard-earned money and bet on the next major money wave, while gaining enough to help ride out the current dire pandemic-related cash tightened setting? Research and investors reveal vaccine-related company stocks as an ongoing and upcoming big investment theme.

Clarity has emerged that multiple COVID-19 vaccines will be ready for distribution in the coming months and more approved vaccines mean more companies that are currently investing millions in making them are set to benefit from a major revenue boost – making it an ideal investment opportunity for individual investors.

With at least 75 per cent of the global population, which currently stands at 7.8 billion, in need of a vaccine, the companies making them are in for billions in revenue boost. And when companies make fortunes, their investors can too.

https://gulfnews.com/your-money/saving-investment/uae-buying-more-vaccine-related-stocks-can-help-ride-the-next-big-investment-boom-1.1606307775295

Lol tomorrows budget vote is really 50/50. Hopefully Ahmad Martadha Mohamed, the professor from Utara Malaysia University is right ie the budget will be approved with a slim majority.

-----------
Malaysia's Government, Prime Minister Face Make-or-Break Budget Vote

UMNO has openly called for general elections once the pandemic is under control. But the holdouts may be keen to bring one on even sooner, confident in the party's chances of wresting control from Muhyiddin and Bersatu, said Ahmad Martadha Mohamed, a professor of government at Utara Malaysia University.

"They feel that if there is a new election UMNO can contest in more seats, especially seats that were taken by Bersatu; they want the seats back and they feel that they have the support," he said.

Ahmad believes the budget is LIKELY TO SQUEAK BY but still sees a chance that it could fail.

https://www.voanews.com/east-asia-pacific/malaysias-government-prime-minister-face-make-or-break-budget-vote

The PP investor must be constellation holdings ltd. from UAE. Just a guess.

@oskchoo From what i understand it is already complete as of today. Maybe someone else can confirm this?

Here's a look at how the different coronavirus vaccines work

https://www.wrcbtv.com/story/42963184/heres-a-look-at-how-the-different-coronavirus-vaccines-work

@okschoon Most probably due to PP. Now that PP is complete and after budget is approved tomorrow, hopefully it will start to go up. Once, Sinopharm vaccine is approved it will move up much more.. Anyway this is long term stock for me due to the bamboo business. Vaccine is just a bonus. I am not concerned with the small movements up or down. If you are contra or short term trader, then don't bother with this stock. Just move on to other counters.

CNBG has vaccine supply agreements with several developing countries including Malaysia, Brazil, Pakistan and the United Arab Emirates, according to public reports compiled by Bloomberg. Leading Western developers like AstraZeneca and Pfizer have inked agreements with far more countries.

CNBG has said that its phase III trials — involving more than 50,000 people in countries from Argentina to Egypt — have been progressing smoothly, and it has not received any reports of serious adverse events.

https://www.theedgemarkets.com/article/china-vaccine-maker-applies-public-use-covid-shot

@eyeHunter Outdated lah you....The budge vote is on track tomorrow...

As for now, the schedule for the crucial Budget 2021 vote set for tomorrow is on track, according to a source familiar with the matter.

https://www.theedgemarkets.com/article/schedule-budget-voting-track-%E2%80%94-source

@18KHarmoni. You must have entered at 0.145. Good price.

Hope the budget will be approved tomorrow....

@aiyooo You are funnier zzzz